11-108271146-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The NM_000051.4(ATM):c.2921C>T(p.Ser974Phe) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000372 in 1,613,450 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000051.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.2921C>T | p.Ser974Phe | missense_variant, splice_region_variant | Exon 19 of 63 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151826Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251336Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135856
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461624Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727160
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151826Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74108
ClinVar
Submissions by phenotype
Ataxia-telangiectasia syndrome Uncertain:2
This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 974 of the ATM protein (p.Ser974Phe). This variant is present in population databases (rs538105098, gnomAD 0.01%). This missense change has been observed in individual(s) with breast cancer (PMID: 30287823). ClinVar contains an entry for this variant (Variation ID: 186354). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not provided Uncertain:2
ATM: PM2, BP4 -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in an individual with breast cancer as well as a control individual (Momozawa et al., 2018); This variant is associated with the following publications: (PMID: 24755471, 24951259, 21798893, 23333482, 19781682, 30287823, 35076389) -
Familial cancer of breast Uncertain:2
The observed missense c.2921C>T p.Ser974Phe variant adjacent to the splice region in ATM gene has been reported previously in individuals affected with ATM-related disorders Momozawa et al., 2018; Romick-Rosendale et al., 2013. The p.Ser974Phe variant is present with allele frequency of 0.001% in gnomAD Exomes. This variant has been submitted to the ClinVar database as Uncertain Significance multiple submissions. Multiple lines of computational evidence Polyphen - Probably Damaging, SIFT - Damaging and MutationTaster - Disease causing predict a damaging effect on protein structure and function for this variant. The reference amino acid of p.Ser974Phe in ATM is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Ser at position 974 is changed to a Phe changing protein sequence and it might alter its composition and physico-chemical properties. Additional functional studies will be required to prove the pathogenicity of this variant. For these reasons, this variant has been classified as a Variant of Uncertain Significance VUS. -
- -
Hereditary cancer-predisposing syndrome Uncertain:2
The p.S974F variant (also known as c.2921C>T), located in coding exon 18 of the ATM gene, results from a C to T substitution at nucleotide position 2921. The serine at codon 974 is replaced by phenylalanine, an amino acid with highly dissimilar properties. This change occurs in the last base pair of coding exon 18, which makes it likely to have some effect on normal mRNA splicing; however, RNA studies have demonstrated that this alteration does not result in abnormal splicing in the set of samples tested (Ambry internal data). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. Based on the available evidence, the clinical significance of this variant remains unclear. -
This missense variant replaces serine with phenylalanine at codon 974 of the ATM protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with breast cancer, but also in unaffected controls (PMID: 30287823). This variant has been identified in 3/251336 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at